In subjects with morbid obesity and T2D, GLP-1R expression in AT is of limited value to predict incretin response and does not play a role in metabolic outcomes such as insulin sensitivity improvement, T2D remission and weight loss after bariatric surgery. Here, GCG is linked to type 2 diabetes mellitus.